LOINC -- all codes Value set

Canonical	../ValueSet/all-loinc
Status	draft · 1.26.0
Source	FSH · JSON

LOINC (Logical Observation Identifiers Names and Codes) -- the international standard for identifying laboratory results, clinical measurements and document types.

This specification pins it in several places: Observation.code.coding[loinc] for results and vitals, DocumentReference.type.coding[loinc] and the Composition classification set for document kinds.

Published by the Regenstrief Institute and the LOINC Committee. Obtain the codes, the release files and the search tools at https://loinc.org. LOINC is available at no cost under the LOINC licence, which does require accepting its terms; LOINC is a registered trademark of Regenstrief Institute, Inc.

The canonical URI is http://loinc.org.

The set enumerates no codes of its own. It includes the whole system, so it means every code in it, and it exists so the system URI resolves to a definition rather than to nothing. The definition itself stays with the publisher at the canonical above: this specification does not redefine the system and does not restrict it. Where this page shows a list of codes, that list is a SAMPLE reproduced under the publisher's own terms and is not the set's content -- the page says how many of how many it is showing.

Codes from http://loinc.org

All codes from this system. 500 of 92,435 are shown below as a sample; this page is not the code system.

Sampled from version 2.83.

Drawn from the 92,435 active LOINC terms that carry no third-party copyright notice. LOINC is larger than that: the release holds 112,405 terms in total, and terms carrying a notice belonging to a third party are excluded here rather than reproduced.

Attribution required by the publisher

This material contains content from LOINC (https://loinc.org). LOINC is copyright (c) 1995+ Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the LOINC licence (https://loinc.org/license). LOINC(R) is a registered United States trademark of Regenstrief Institute, Inc. Terms carrying a third-party copyright notice are not reproduced here.

Code	Display
1-8	Acyclovir [Susceptibility]
100189-0	How bothersome is knee when moving laterally
100375-5	Anise IgG Ab [Units/volume] in Serum
100541-2	Trauma Outpatient Progress Note
100709-5	Hepatocellular carcinoma risk [Score] by GAAD
100892-9	Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
101074-3	CEVF Ab [Presence] in Serum or Plasma
101258-2	Identification information during assessment period [CMS Assessment]
101426-5	Respiratory syncytial virus B RNA [Presence] in Respiratory system specimen by NAA with probe detection
101599-9	CMS - Self-Care - OBRA during assessment period [CMS Assessment]
101775-5	Nannizzia fulva DNA [Presence] in Specimen by NAA with probe detection
10196-4	Physical findings of Extremities Narrative
102139-3	Anchovy IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102306-8	Finch feather IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102473-6	Oat pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102640-0	Turkey meat IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102806-7	Rape Pollen IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
102973-5	Bean string IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST)
103139-2	Systemic lupus Ab panel - Serum or Plasma
103307-5	XR Lumbar spine 2 Views W flexion and W extension
103474-3	XR Acromioclavicular joint - left Views WO weight
103653-2	Ciprofloxacin [Susceptibility] for meningitis
103852-0	RFA Guidance for angioplasty of Extremity vessels - bilateral -- W contrast
10404-2	Inject Rh immune globulin [Volume]
104213-4	Views screening for diabetic retinopathy of Left eye
104395-9	European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen
104588-9	Emergency Medicine Team Conference Note
104765-3	Neisseria gonorrhoeae DNA [Presence] in Specimen by Molgen
104937-8	CT Spine [Mass/volume] Multisection for bone density
105108-5	Erythrocytes [#/volume] in Urine sediment
105329-7	Hereditary angioedema multigene analysis in Blood by Molecular genetics method
105579-7	Discontinued medication list [Identifier] Episode Pharmacy
105763-7	Mycobacterium tuberculosis pncA promoter region gene pyrazinamide resistance mutation [Identifier] in Isolate or Specimen by Molecular genetics method Nominal
105966-6	Norbuprenorphine [Presence] in Urine
106208-2	Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Aspirate by NAA with probe detection
106421-1	Total score [Three-Item Loneliness Scale]
106599-4	Neisseria meningitidis DNA [Presence] in Body fluid by NAA with non-probe detection
106784-2	Membranous nephropathy associated antigens analysis in Tissue by LC/MS/MS
106983-0	Testis expressed Protein 101 [Mass/volume] in Semen by Immunoassay
10718-5	Strongyloides sp Ab [Units/volume] in Serum by Immunoassay
10737-5	Virus identified in Stool by Electron microscopy
107559-7	Lipase [Enzymatic activity/volume] in Drain
107741-1	Quail meat IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
107916-9	HLA-A and B and C (class I) Ab.IgG present [Identifier] in Serum or Plasma by Immunoassay
108137-1	Pathologist diagnosis date in Report
10853-0	Isospora belli [Presence] in Specimen by Acid fast stain.Kinyoun modified
11031-2	Lymphocytes/Leukocytes in Body fluid
111535-1	Albumin transudation rate [Complex] by calculation
111705-0	Left eye Foveal Point Probability Value Static Automated Perimetry
111873-6	Image-Enhanced endoscopy ERCP
11204-5	Ulocladium chartarum IgE Ab [Units/volume] in Serum
112215-9	Shrimp Allergen mix (White, Brown and Pink shrimp) IgE Ab [Units/volume] in Serum or Plasma by Immunoassay
112458-5	CD3 cells in Specimen from Donor Qualitative
11263-1	Parainfluenza virus 3 IgM Ab [Titer] in Serum
112817-2	Apple recombinant (rMal d) 1 IgE Ab [Units/volume] in Serum or Plasma by Immunoassay
112989-9	Buckwheat (Fagopyrum esculentum) Fag e 2 IgE Ab [Units/volume] in Serum or Plasma by Immunoassay
113218-2	Tetrahydrocannabinol [Presence] in Serum or Plasma by Immunoassay
113390-9	Eszopiclone and Zopiclone [Mass/volume] in Urine
113557-3	Propoxyphene [Presence] in Urine by Immunoassay
113723-1	Norbuprenorphine [Presence] in Saliva (oral fluid) by Immunoassay
113891-6	LORazepam [Mass/volume] in Serum or Plasma by Immunoassay
11406-6	Physical findings of Hip Narrative
114227-2	p-Fluorofentanyl [Mass/volume] in Urine
114406-2	oxyCODONE+oxyMORphone [Presence] in Meconium by Immunoassay
114585-3	Streptococcus intermedius DNA [Presence] in Specimen by Molgen
11476-9	Microscopic observation [Identifier] in Gastric fluid by Acid fast stain
11493-4	Hospital discharge studies summary Narrative
115104-2	Escherichia coli enteroaggregative DNA [Presence] in Specimen by Molgen
115274-3	Candida sp DNA [Presence] in Specimen by Molgen
115449-1	Adenovirus B(16) DNA [Presence] in Specimen by Molgen
115634-8	Availability of healthy foods scale score [Neighborhood scale]
1167-6	little f Ab [Presence] in Serum or Plasma from Donor
11852-1	Fetal Head Diameter.outer to outer US
12030-3	Fetal Abdominal wall Study observation US
12203-6	Cryoglobulin [Presence] in Serum by 3 day cold incubation
12387-7	Primidone [Mass/volume] in Urine
12572-4	Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen
12795-1	Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge
12977-5	Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen
13213-4	Brucella abortus IgM Ab [Units/volume] in Cerebrospinal Fluid
13409-8	Phenylalanine [Mass/volume] in Amniotic fluid
13589-7	Activated protein C resistance [Presence] in Blood by NAA with probe detection
13817-2	Tryptophan/Creatinine [Mass Ratio] in Urine
13998-0	Neuronal nuclear type 2 Ab [Titer] in Serum
14177-0	Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma
14357-8	Microscopic observation [Identifier] in Cerebrospinal Fluid by Gram stain
14535-9	Measles virus Ag [Presence] in Throat by Immunofluorescence
14711-6	EPINEPHrine [Moles/volume] in Plasma
1489-4	Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin
1506-5	Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO
15238-9	Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk
15416-1	Service comment 25
16119-0	Brucella abortus IgG Ab [Titer] in Serum
16323-8	Alanine [Presence] in Urine
16529-0	Campylobacter jejuni rRNA [Units/volume] in Serum by Probe
16724-7	Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge
16925-0	Haemophilus influenzae A Ag [Presence] in Urine
17104-1	CD107a cells/cells in Blood
1729-3	Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells
17484-7	Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge
17696-6	Tetrachlorodiphenylethane [Mass/volume] in Urine
17875-6	Bacteria # 4 identified in Bone by Aerobe culture
18047-1	Left ventricular Ejection fraction by US 2D modified biplane
18221-2	EPINEPHrine [Mass/volume] in Urine --4th specimen post XXX challenge
18412-7	Stemphylium botryosum IgG Ab [Units/volume] in Serum
18619-7	Discharge medication Dose
18875-5	Cefadroxil [Susceptibility]
19089-2	Collection of urine specimen start time
1930-7	Benzoate [Mass/volume] in Serum or Plasma
1953-9	Beta-2-Microglobulin [Mass/volume] in Urine
19751-7	Mouse epithelium, serum proteins + urine proteins IgE Ab [Units/volume] in Serum
1992-7	Calcitonin [Mass/volume] in Serum or Plasma
20114-5	Tidal volume sigh spontaneous+mechanical --on ventilator
20290-3	Pulmonic valve Region orifice area by US.doppler Vmax + diameter calculated
20464-4	Toxoplasma gondii Ab [Interpretation] in Serum
20665-6	Echovirus 14 neutralizing antibody [Titer] in Serum by Neutralization test
20843-9	Avian infectious laryngotracheitis virus Ag [Presence] in Trachea by Immunofluorescence
2102-2	Chondroitin sulfate [Mass/volume] in Urine
2128-7	Citrate [Mass/volume] in Urine
21529-3	Volume of 8 hour Urine
21736-4	SNCA gene p.Ala30Pro [Presence] in Blood or Tissue by Molecular genetics method
21907-1	Distant metastases.clinical [Class] Cancer
22093-9	Infectious bronchitis virus Conn-42 Ab [Titer] in Serum
22264-6	Echinococcus granulosus IgG Ab [Presence] in Serum
22443-6	Plasmodium ovale Ab [Titer] in Serum
22642-3	Tyrosine [Moles/volume] in Cerebrospinal Fluid
22820-5	Avian orthoreovirus Ag [Presence] in Specimen
23-2	Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)
23168-8	Leptospira borgpetersenii sv Ballum Ab [Presence] in Serum by Agglutination
23340-3	Paratuberculosis reaction wheal [Diameter] --3 days post 0.1 mL johnin intradermal
23520-0	Trypanosoma evansi [Presence] in Aspirate by Wet preparation
23702-4	Canine parvovirus Ab [Titer] in Serum
23885-7	Isoheptacarboxylporphyrin [Mass/time] in unspecified time Stool
24079-6	Cholesterol esterase [Enzymatic activity/mass] in Fibroblast
24268-5	Coxsackievirus B5 Ab [Titer] in Serum --2nd specimen
24467-3	CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24645-4	Portable XR Chest PA and Right lateral and Right oblique and Left oblique upright
2484-4	Insulin-like growth factor-I [Mass/volume] in Serum or Plasma
25038-1	Courtesy consultation Document
25218-9	Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 0.2 ug/mL
25423-5	Trichinella spiralis IgG Ab [Units/volume] in Serum by Immunoassay
25639-6	Follitropin [Units/volume] in Urine by 2nd IRP
2584-1	Lysine [Presence] in Serum or Plasma
26012-5	17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine --1 day post XXX challenge
26197-4	MR Thigh - left WO and W contrast IV
26371-5	RFA Guidance for angioplasty of Iliac artery - left-- W contrast IA
2656-7	Niacin [Mass/time] in 24 hour Urine
26736-9	Promethazine [Presence] in Serum or Plasma
26927-4	Herpes simplex virus 2 IgM Ab [Titer] in Serum by Immunofluorescence
27100-7	Probenecid [Mass/volume] in Serum or Plasma
27298-9	Protein [Units/volume] in Urine
27713-7	Respiratory therapy treatment plan, Date range (from/through) of hospitalization leading to treatment Set
2797-9	Phosphoglucomutase [Enzymatic activity/volume] in Serum
28150-1	Cardiovascular alteration [CCC]
28321-8	Personal Care Knowledge [OMAHA]
28490-1	Genito-urinary function.knowledge Family [OMAHA]
28663-3	Right eye Sphere far by Phoropter
28839-9	Right glasses lens prescription Visual acuity near
29004-9	Left eye Tear secretion 1 Schirmer test
2922-3	Retinol [Mass/volume] in Blood
2940-5	Serotonin [Mass/volume] in Plasma
29573-3	Phenylalanine [Moles/volume] in DBS
29746-5	Cryoglobulin [Presence] in Serum by 3 day 37 degree C incubation
29918-0	Bismuth [Mass/time] in 24 hour Urine
30088-9	Horse hair+Horse dander IgE Ab [Units/volume] in Serum
30261-2	Insulin [Units/volume] in Serum or Plasma --3.5 hours post XXX challenge
3044-5	Triglyceride+ester in HDL [Mass/volume] in Serum or Plasma
30625-8	CT Lower extremity WO contrast
30802-3	CT Maxillofacial region WO contrast
30980-7	Date vaccine due
31152-2	Immunoglobulin light chains [Presence] in 24 hour Urine
31322-1	Coxsackievirus A9 Ab [Units/volume] in Body fluid
31499-7	Ganglioside GM1 IgG Ab [Units/volume] in Serum
31687-7	Trichinella sp IgM Ab [Units/volume] in Serum
31860-0	Influenza virus A+B Ag [Presence] in Throat
32031-7	Phosphatidylserine IgA Ab [Units/volume] in Serum by Immunoassay
32200-8	Segmented neutrophils/Leukocytes in Blood by Automated count
32372-5	Fleroxacin [Susceptibility]
32542-3	Chloride [Molar amount] in Urine collected for unspecified duration
3272-2	LMW Heparin [Mass/time] in 24 hour Urine
32897-1	Height {Tooth} Measured
3307-6	Alfentanil [Mass/volume] in Serum or Plasma
33239-5	Ammonium urate crystals [Presence] in Urine by Computer assisted method
3343-1	Amoxapine [Mass/volume] in Urine
33603-2	Bactericidal permeability increasing protein IgG Ab [Units/volume] in Serum
33782-4	Retinol binding protein [Mass/volume] in Urine
33953-1	Immune complex IgA [Mass/volume] in Serum or Plasma
3412-4	Bupivacaine [Mass/volume] in Serum or Plasma
34293-1	Estriol (E3)/Creatinine [Molar ratio] in Urine
34465-5	B Ab [Titer] in Serum or Plasma by Immediate spin
34639-5	Epstein Barr virus capsid IgA Ab [Titer] in Cerebrospinal Fluid
34815-1	Orthopaedic Surgery Note
34988-6	Unidentified cells [#/volume] in Body fluid
35162-7	Palmitoleate (C16:1w7) [Moles/volume] in Serum or Plasma
35405-0	Leishmania brasilensis IgM Ab [Presence] in Serum
35576-8	Hydrocarbon and Oxygenated Volatiles panel - Serum or Plasma
35756-6	Avilamycin [Susceptibility]
35922-4	CT Guidance for drainage and placement of drainage catheter of Unspecified body region
36092-5	CT Hip limited
36263-2	MR Lower leg - right W contrast IV
36435-6	MR Face WO contrast
36608-8	XR Elbow Oblique Views
36776-3	XR tomography Mastoid
36961-1	XR Shoulder - left AP and West Point and Outlet
37135-1	XR Ankle - left Lateral and Mortise
37357-1	XR Lumbar spine and Sacrum and SI joint and Coccyx 5 Views
37563-4	XR Thumb - bilateral Views W manual stress
37739-0	RFA Iliac artery - right Views W contrast IA
37913-1	US Guidance for biopsy of Abdomen
38100-4	RF Urinary bladder and Urethra Views W contrast antegrade
38288-7	1,2-Dibromo-3-Chloropropane [Mass/volume] in Water
38460-2	Legionella sp Ag [Presence] in Bronchial specimen by Immunofluorescence
3863-8	Norethandrolone [Presence] in Urine
38798-5	XR Olecranon - right Views
39018-7	Coliform bacteria [#/mass] in Specimen by Viability count
39198-7	Neurologic screen follow-up status CPHS
39367-8	XR Thoracic and lumbar spine AP and lateral for scoliosis W standing
39535-0	Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA)
39710-9	SPECT Heart perfusion W Tc-99m Sestamibi IV
39890-9	NM Heart First pass and Wall motion
40064-8	Calcium [Mass/volume] in Serum or Plasma --pre XXX challenge
40230-5	Calcium [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge
404-4	Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)
4057-6	Tobramycin [Mass/volume] in Serum or Plasma --peak
40748-6	Dengue virus Ab [Presence] in Serum by Hemagglutination inhibition
40940-9	Yersinia sp Ab [Titer] in Serum
41113-2	Chronic lymphocytic leukemia gene mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
41283-3	HLA-DQ8 [Presence]
41460-7	SARS coronavirus IgG Ab [Presence] in Serum by Immunoassay
41703-0	Moxalactam [Susceptibility] by Gradient strip
41898-8	Vendor device model code of Glucose meter
42068-7	Summary stage and TNM-N override flag Cancer case
42250-1	Variant lymphocytes/Leukocytes in Blood by Automated count
42428-3	XR Thoracic and lumbar spine AP for scoliosis W standing in brace
42605-6	Peritoneal dialysis bag number
42797-1	Age at first pregnancy
42976-1	PRRSV Ab [Titer] in Serum
43146-0	Oxygen saturation device panel
4332-3	Mexiletine [Mass] of Dose
435-8	Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC)
43689-9	HLA-DQ2 and HLA-DQ8 [Interpretation]
43861-4	Asialoganglioside GM1 Ab [Presence] in Serum
4403-2	Piperacillin [Mass] of Dose
44209-5	XR Sinuses Limited Views
44404-2	Silicon/Creatinine [Mass Ratio] in Urine
44573-4	Influenza virus B Ag [Presence] in Nose by Immunofluorescence
44767-2	Relationship of subject to patient
44938-9	Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay
45127-8	Vesicular stomatitis New Jersey virus Ag [Presence] in Specimen by Immunoassay
45335-7	Bacteria Identification [Presence] in Isolate by Culture
4604-5	Hemoglobin Lepore [Presence] in Blood by Electrophoresis acid (pH 6.3)
46293-7	CT Guidance for drainage and placement of drainage catheter of Unspecified body region-- WO contrast
46499-0	State of residence
46791-0	Caretaking/parenting.status Community [OMAHA]
4696-1	HLA-A19 [Presence]
47132-6	Thioridazine [Moles/volume] in Urine
47312-4	Influenza virus A IgM Ab [Units/volume] in Serum by Immunoassay
47529-3	Cytology report of Tissue Other stain
47697-8	Mandelate/Creatinine [Molar ratio] in Urine
47871-9	Prolactin [Units/volume] in Serum or Plasma --30 minutes post dose metoclopramide
4804-1	HLA-B12 [Presence] in Donor
48209-1	Orange triggered leukotriene release [Mass/volume] by Leukocytes
48378-4	Kappa light chains.free/Lambda light chains.free [Mass Ratio] in Serum
48549-0	HIV-Signs and Symptoms Checklist (SSC) panel
48727-2	Bacteria # 2 identified in Blood by Culture
48900-5	Orientia tsutsugamushi Kato IgG Ab [Titer] in Body fluid by Immunofluorescence
49073-0	Influenza virus A IgG Ab [Mass/volume] in Cerebrospinal Fluid
49241-3	Xylose absorption [Interpretation] in Urine and Serum or Plasma Narrative
4941-1	HLA-DQ5(1) [Presence]
49581-2	Referral lab test identifier and name [Identifier]
49755-2	Crystals [Presence] in Urine sediment by Light microscopy
49927-7	Amylase in fluid/Amylase in serum
50095-9	21-Deoxycortisol [Moles/volume] in Serum or Plasma --pre 250 ug corticotropin
50266-6	2-Dechloroethylifosfamide [Mass/volume] in Blood --1 day post dose ifosfamide
50439-9	Corticotropin [Mass/volume] in Plasma --3 AM specimen
50608-9	Glucose tolerance 3 hours gestational panel - Serum or Plasma
50790-5	HIV 1 RNA tropism [Identifier]
50961-2	Rabbit Ab [Titer] in Serum
51127-9	CD22 blasts [Units/volume] in Bone marrow
51297-0	CD38 cells/Cells in Cerebrospinal Fluid
51465-3	Paragonimus sp Ab [Titer] in Pleural fluid
51659-1	Hepatitis B virus surface Ag [Presence] in Body fluid
5183-9	Hepatitis A virus Ab [Units/volume] in Serum or Plasma by Immunoassay
52004-9	Ambulance transport, Rationale for wait time Set
52341-5	Respiratory therapy treatment plan, Responsible rehabilitation professional information Set
52833-1	Survey reporting period end date Facility
53033-7	Include all data of the selected type that represents observations made two years or less before the starting date of service
53200-2	Argininosuccinate/Arginine [Molar ratio] in DBS
53372-9	Echovirus IgM Ab [Titer] in Serum
53540-1	Alpha globulin.abnormal band/Protein.total in Serum or Plasma by Electrophoresis
53709-2	Glial nuclear type 1 Ab [Titer] in Serum
53883-5	OCRL1 mutations found [Identifier] in Blood or Tissue by Targeted gene mutation analysis Nominal
54079-9	Galactosemia newborn screening panel
54266-2	Glucose [Moles/volume] in Serum or Plasma --1.3 hours post dose insulin IV
54449-4	SMN2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
54695-2	Wandering significantly intrudes on the privacy or activities of others in last 7 days [CMS Assessment]
54902-2	IgM [Mass/volume] in Peritoneal fluid
55101-0	Respiratory pathogens panel - Specimen by Organism specific culture
55293-5	Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC)
55500-3	Insulin [Moles/volume] in Serum or Plasma --30 minutes post dose glucagon
5568-1	Acetone [Mass/volume] in Serum or Plasma
55867-6	Choriogonadotropin.beta subunit free [Mass/volume] in Body fluid
56032-6	Lithium [Moles/volume] in Gastric fluid
56253-8	Egg white IgG4 Ab [Mass/volume] in Serum
56420-3	White Ash IgG4 Ab [Mass/volume] in Serum
56591-1	Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge
56764-4	Oligoclonal Bands IgG [Presence] in Cerebrospinal Fluid by Isoelectric focusing
56934-3	Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hour post dose lactulose
57102-6	Lutropin [Units/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone
57298-2	HLA-DRB1 [Type]
57473-1	Calcitriol [Moles/volume] in Serum or Plasma --1 hour post dose calcium
57640-5	Androsterone [Mass/time] in 24 hour Urine --2 days post high dose dexamethasone
57827-8	Reason for co-payment exemption Document
58002-7	Mestanolone metabolite [Presence] in Urine
58189-2	Physical restraints - care area triggered [MDSv3]
58470-6	Nucleated cells [#/volume] in Cerebrospinal Fluid
58636-2	Cortisol [Moles/volume] in Serum or Plasma --10 PM specimen
5881-8	Varicella zoster virus Ag [Presence] in Skin by Immunofluorescence
58983-8	Honey bee phospholipase A2 native (nApi m) 1 IgE Ab [Units/volume] in Serum
59156-0	Glucose [Moles/volume] in Urine by Automated test strip
59331-9	Dinorsibutramine [Mass/volume] in Blood
59536-3	Derived pre treatment-7 N Cancer
59739-3	Silver [Mass/mass] in Nail
59915-9	Indomethacin [Moles/volume] in Gastric fluid
60080-9	Germanium [Mass/volume] in Red Blood Cells
60256-5	Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection
60428-0	Toxoplasma gondii IgA Ab [Titer] in Serum
6062-4	Casein IgE Ab [Units/volume] in Serum
60868-7	Oxygen/Gas total Gas delivery system --during inspiration
6110-1	English plantain IgE Ab [Units/volume] in Serum
61277-0	Isocyanate HDI IgE Ab/IgE total in Serum
616-3	Bacteria identified in Line specimen by IV Line culture
6236-4	Cultivated Rye IgE Ab [Units/volume] in Serum
626-2	Bacteria identified in Throat by Culture
62944-4	PhenX - exposures to violence - adult protocol 181401
63177-0	Acremonium sp IgG Ab [Mass/volume] in Serum
63343-8	Sjogrens syndrome-A extractable nuclear 60kD Ab [Presence] in Body fluid by Immunoassay
63540-9	Ribonucleoprotein extractable nuclear Ab [Presence] in Body fluid
63722-3	Was the private well cased [Next-of-kin]
6394-1	Echovirus 40 Ab [Titer] in Serum by Complement fixation
64329-6	Home patients starting dialysis for first time ever Population #
64914-5	I feel nervous with people I don't know well [SCARED-R]
65086-1	Your child finds it easy to work out what someone is thinking or feeling just by looking at their face [AQ Adolescent]
65330-3	MER2 Ab [Presence] in Serum or Plasma
65652-0	Testing facility name
65951-6	Anhedonia [DI-PAD]
66236-1	Do you lose your balance because of dizziness or do you ever lose consciousness [Revised PARQ]
66705-5	I tend to stop and think before doing things [UPPS-R-Child]
66887-1	How old were you the first time it happened [LTVH]
67213-9	Disease stage
6770-2	Alpha 1 antitrypsin phenotype [Identifier] in Serum or Plasma by Immunofixation
68381-3	pH of Synovial fluid by Test strip
68580-0	Orthopaedic Surgery History and Physical Note
68770-7	Pediatric Nephrology History and Physical Note
68965-3	Rg Ag [Presence] on Red Blood Cells
69157-6	XR Wrist - left Lateral Views W flexion and W extension
69348-1	Respiratory assist status
6964-1	Yersinia enterocolitica IgA Ab [Units/volume] in Serum by Immunoassay
699-9	Organism count [#/volume] in Specimen by Microscopic count
7008-6	Doxycycline [Susceptibility] by Gradient strip
70269-6	Triglyceride in pleural fluid/Triglyceride in serum
7115-9	Barley triggered histamine release [Units/volume] in Blood
71647-2	Basophils/Leukocytes [Pure number fraction] in Body fluid by Manual count
71854-4	Deoxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Arterial blood
7224-9	Chicken feather IgG Ab [Units/volume] in Serum
7242-1	Codfish triggered histamine release [Units/volume] in Blood
7260-3	Crab IgG Ab [Units/volume] in Serum
72843-6	Hepatitis B virus codon 215 [Identifier] by Genotype method
73014-3	Gentamicin induced neutrophil IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73184-4	Pseudoephedrine induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73350-1	hydroCHLOROthiazide+Losartan induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73517-5	Atenolol induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
73688-4	Danazol [Presence] in Urine by Screen method
7387-4	Halibut triggered histamine release [Units/volume] in Blood
74046-4	Supplemental information about periodontal condition
74279-1	Gamma interferon negative control spot count [#] in Blood
74449-0	Patient plan of care - recommended IHE set
74637-0	Protein.monoclonal band 2 [Mass/time] in 24 hour Urine by Electrophoresis
74842-6	CD25 cells [#/volume] in Specimen
75032-3	CEBPA gene full mutation analysis in Bone marrow by Sequencing
75204-8	Prenatal care indicator [CDC.CS]
75422-6	Addiction Psychiatry Group Counseling Note
75600-7	Fetal 1p36 deletion risk [Likelihood] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
75816-9	RF Spine.thoracic epidural space Views W contrast epidural
76040-5	levoFLOXacin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mL
76257-5	Air cylinder Pressure
76491-0	IgM [Moles/volume] in Serum or Plasma
76666-7	Protein [Mass/volume] in Cerebrospinal Fluid --2nd tube
77100-6	MRPL18A gene full mutation analysis in Blood or Tissue by Sequencing
77350-7	Erythropoietin (EPO) Ab [Presence] in Serum
77574-2	Global measure of physical function panel APTA
77754-0	2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Confirmatory method
78010-6	HIV 1 proviral DNA [Logarithmic entitic number] (viral load) in Mononuclear cells from unspecified specimen by NAA with probe detection
78310-0	Hematology Initial Evaluation Note
78495-9	Anesthesiology Checklist
78680-6	Vascular Surgery Transfer Summary Note
78864-6	Naloxone cutoff [Mass/volume] in Urine for Confirmatory method
79093-1	CT Unspecified body region 3D post processing
79284-6	Carnitine biosynthesis intermediates panel - DBS
79468-5	Thiopurine methyltransferase [Enzymatic activity/substance] in Red Blood Cells
79648-2	D-serine [Moles/volume] in Cerebrospinal Fluid
79813-2	Right cornea Corneal curvature by Keratometry
79982-5	Left atrial End-systolic volume (by US.2D+Calculated by biplane area-length method)/Body surface area
8015-0	Rubella virus IgM Ab [Units/volume] in Serum
80318-9	Respiratory assessment panel
80509-3	MR Guidance for placement of clip in Unspecified body region
80684-4	Campylobacter coli+jejuni+lari 16S rRNA [Presence] in Stool by NAA with probe detection
80853-5	US Guidance for injection of Elbow
81018-4	Vitamin B7 (Biotin) intake 24 hour Measured
81185-1	Non-regional lymph nodes positive [#] in Specimen
81389-9	Right ventricular Stroke volume by US.continuity.VTI+Diameter
81633-0	Oncology Recommended follow-up tests or procedures
81829-4	SDHA gene full mutation analysis in Blood or Tissue by Sequencing
82061-3	Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab RAST class [Presence] in Serum by Multidisk
82258-5	Subtelomere analysis in Bone marrow by FISH
82472-2	Borrelia garinii+afzelii oppA1 gene [Presence] in Specimen by NAA with non-probe detection
8265-1	Service comment 04
82827-7	Colon and Rectal Surgery Initial Evaluation Note
83032-3	XR Hip GE 2 Views preoperative
83234-5	Prior device use during assessment period [CMS Assessment]
83560-3	Primary Care Nurse Practitioner Note
83733-6	Physical Medicine and Rehab Telephone Encounter Note
83901-9	Psychology History and Physical Note
84075-1	Intensive Care Unit Admission Evaluation Note
84240-1	Nurse Administrative Note
84430-8	Occupational Therapy Interdisciplinary Note
85097-4	Meta methylhippurate and ortho methylhippurate and para methylhippurate and creatinine panel - Urine
85307-7	Distance of carcinoma from medial margin [Length] in Breast cancer specimen by Light microscopy
855-7	A2 Ag [Presence] on Red Blood Cells from Donor
85706-0	Mother's date of exposure to individual with confirmed illness
85880-3	Long Term Care Facility Restraint Note
86051-0	Streptococcus pneumoniae Danish serotype 20A IgG Ab [Ratio] in Serum --2nd specimen/1st specimen
86219-3	Porcine epidemic diarrhea virus IgG Ab [Titer] in Serum by Immunofluorescence
86401-7	RF Urinary bladder Views W contrast intra bladder
8660-3	History of Cardiovascular system disorders
86779-6	Number of days of training and skill practice in walking in last 7 calendar days [CMS Assessment]
86972-7	CT Head and Neck WO and W contrast IV
8714-8	Physical findings of Sense of touch
87308-3	Guidance for transhepatic removal of catheter of Biliary ducts
8748-6	Left ventricular Cardiac index by Spiral CT
87655-7	Heptachlor epoxide [Mass/mass] in Specimen
87887-6	CT Finger fourth - left W contrast IV
88058-3	Respiratory measurements Document
88233-2	Babesia sp DNA [Presence] in Blood by NAA with probe detection
88431-2	Vigorous physical activity.leisure-time domain [IPAQ]
88613-5	Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection
88858-6	Donor type score for risk calculation
89036-8	Trauma Note
89306-5	Nortapentadol [Presence] in Urine by Screen method
89482-4	Kanamycin [Susceptibility] by Genotype method
89696-9	CT Guidance for drainage and placement of drainage catheter of Pelvis-- W contrast IV
8987-0	Fluid intake 8 hour
90075-3	Non-Enterobacteriaceae identified in Isolate by Organism specific culture
90335-1	CT Guidance for injection of Lumbar Spine Facet Joint
90546-3	Occupational therapy since the start date of the resident's most recent Medicare Part A stay [CMS Assessment]
90844-2	PCA-Tr Ab [Presence] in Cerebrospinal Fluid by Cell binding immunofluorescent assay
91083-6	Fungal 18s rRNA gene [Presence] in Isolate by NAA with probe detection
91571-0	Frequency of drug injection in past 12 months
91815-1	Bordetella pertussis DNA [Presence] in Upper respiratory specimen by NAA with probe detection
92130-4	Rhinovirus RNA [Presence] in Respiratory system specimen by NAA with probe detection
92545-3	Do sup(b) Ag inferred phenotype [Presence] in Blood or Tissue from Donor by Molecular genetics method
92767-3	Listeria sp DNA [Presence] by NAA with probe detection in Positive blood culture
92934-9	9p21 g.22124478A>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal
93162-6	IRF-PAI v4.0 - Cognitive patterns - admission during assessment period [CMS Assessment]
93362-2	Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
93632-8	Heart Left ventricular outflow tract/Aortic valve VTI by US.doppler
93821-7	Calories burned in unspecified time --during aerobic activity
9399-7	Ribonucleoprotein extractable nuclear Ab [Titer] in Serum
94198-9	DPYD gene full mutation analysis in Blood or Tissue by Sequencing
94379-5	Enterobacter cloacae complex DNA [Presence] in Lower respiratory specimen by NAA with probe detection
94560-0	Diabetes risk [Score] Calculated
94732-5	DULoxetine [Presence] in Saliva (oral fluid) by Confirmatory method
9490-4	Aspergillus flavus Ab [Presence] in Serum
9508-3	Chlorothiazide [Presence] in Urine
95249-9	In the last 12 months, did you ever cut the size of your meals or skip meals because there wasn't enough money for food
95433-9	During the past 3 months, how often have you used methamphetamine
95606-0	Stress level - 0-10 numeric rating [Score] 24 hour maximum
95785-2	FOXL2 gene targeted mutation analysis in Tissue by Molecular genetics method
95966-8	Aspergillus glaucus IgE Ab [Units/volume] in Serum
96219-1	Right retina Functional findings [Interpretation] by ERG
96386-8	Physical impairment information Document
96552-5	Result of most recent lab test for condition of interest
96724-0	Alveolar macrophages [#/volume] in Lower respiratory specimen by Manual count
96909-7	Cenobamate [Mass/volume] in Serum or Plasma by Confirmatory method
97091-3	How often Federal Government used as source of information for COVID-19
97276-0	Methylone [Presence] in Cord tissue by Screen method
97462-6	XR Toe third - left Lateral
97634-0	Staphylococcus aureus DNA [Presence] in Synovial fluid by NAA with non-probe detection
97805-6	Extent of spine segment or vertebral body lesion
97990-6	von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Immunoassay
98161-3	Monthly household net income
98329-6	XR Spine thoracolumbar junction AP
98517-6	Duration of shortness of breath in past 7 days
98748-7	Right eye Horizontal prism - in for far phoria by Phoropter
98919-4	Satisfaction with health in last 2 weeks
99094-5	Streptococcus pneumoniae DNA [Presence] in Cerebrospinal Fluid by NAA with probe detection
99280-0	Cefiderocol [Susceptibility]
9948-1	Q wave duration in lead V6
99661-1	Number of family members or close friends that have been infected with condition of interest
99829-4	Frequency of conveying meaningful simple messages in routine low demand situations

End of sample. 500 of 92,435 codes are listed above; the remaining 91,935 are not shown. This page is a sample of the code system, not the code system -- obtain the full set from its publisher.